Telesis Bio Inc.
TBIOOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|
| Revenue | $27.5M | $27.4M | $11.0M | $6.6M |
| Operating income | −$46.5M | −$46.5M | −$35.4M | −$16.4M |
| Net income | −$47.7M | −$48.5M | −$39.0M | −$18.0M |
| Total assets | $70.4M | $81.4M | $116.3M | $26.9M |
| Total liabilities | $40.9M | $34.8M | $25.5M | $13.4M |
| Equity | $238,000 | $46.6M | $90.8M | −$25.5M |
| EPS (diluted) | $-1.64 | $-1.65 | $-2.14 | $-3.60 |
| Shares out. | 29.6M | 29.3M | 29.3M | 5.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2023- Operating margin
- −169.2%
- Net margin
- −173.5%
- Return on equity
- −20052.1%
- Return on assets
- −67.8%
- Return on capital (ROCE)
- −74.8%
- Liabilities / assets
- 58.0%
- Debt / equity
- 171.74×
- Book value / share
- $0.01
- Revenue growth (YoY)
- 0.3%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2023- Altman Z″ (distress)
- -9.85distress
- Accruals / assets
- −18.5%clean
- Piotroski F-Score
- 3/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Krueger ToddDirector | Jul 24, 2024 | Grant | 8,390 | $0.00 |
| Golub Steven JDirector | Jul 24, 2024 | Grant | 8,390 | $0.00 |
| Hlavinka Sarah E.Director | Jul 24, 2024 | Grant | 8,390 | $0.00 |
| Hodges Michael R.Director | Jul 24, 2024 | Grant | 8,390 | $0.00 |
| Weissman James BDirector | Jul 24, 2024 | Grant | 8,390 | $0.00 |
| Witney FrankDirector | Jul 6, 2023 | Grant | 46,752 | $0.00 |
| Tumolo AnnetteDirector | Jul 6, 2023 | Grant | 46,752 | $0.00 |
| Tsingos Christine ADirector | Jul 6, 2023 | Grant | 46,752 | $0.00 |
| Nachtsheim Jami KDirector | Jul 6, 2023 | Grant | 46,752 | $0.00 |
| Herrema Gregory J.Director | May 1, 2024 | Grant | 31,486 | $0.00 |
| Esser Eric EugeneOfficer — President & CEO | Apr 17, 2024 | Grant | 100,000 | $0.00 |
| Nelson Todd RobertOfficer — Chief Executive Officer | Jun 22, 2023 | Grant | 47,700 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 177 | 1.0 | +115.8% |
| Apr 30, 2026 | 82 | 1.0 | 0.0% |
| Apr 15, 2026 | 82 | 1.0 | 0.0% |
| Mar 31, 2026 | 82 | 1.0 | 0.0% |
| Mar 13, 2026 | 82 | 1.0 | 0.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreementNov 8, 2024
- Director / officer changeOct 25, 2024
- Delisting / listing-standard noticeSep 10, 2024
- Other material eventAug 30, 2024
- Other material eventAug 28, 2024
- Entered a material agreementAug 20, 2024
- Results of operationsAug 7, 2024
- Entered a material agreement · Terminated a material agreement · Director / officer changeJul 18, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.